Specific Application FAQs

This issue is often related to transfer efficiency, antibody concentration, or sample quality. Start by verifying whether the protein transfer was successful. Even if the transfer process is correct, then the issue may be low antibody level or damaged antibodies. For that reason, increase the antibody level or make new antibodies. Also, you can try loading additional sample or changing the lysis buffer composition if target protein isn’t expressed to increase protein removal rate.

Excessive background may result from insufficient blocking, overly high antibody concentrations, or inadequate washing. To address this, consider extending the blocking duration and using fresh blocking solutions, such as 5% non-fat milk or BSA, while ensuring that the blocking agent does not react with the antibodies. Then, if that still isn’t working, reduce the primary and secondary antibodies and up the washing speed and time. Further, longer exposure times can be used to make the background noise appear stronger, and should therefore be minimized if you can.

Nonspecific bands may arise from insufficient antibody specificity or sample degradation. To minimize nonspecific binding, it is recommended to use monoclonal antibodies or affinity-purified polyclonal antibodies. During sample preparation, ensure the addition of protease inhibitors to prevent protein degradation. If these factors are not the issue, consider reducing the sample loading amount, as excessive protein can lead to nonspecific band formation.

Bad storage (freeze-thaw cycles, for example, are the most common causes of antibody degradation). To avoid this, aliquot the antibody and store it at -20°C or -80°C, minimizing freeze-thaw cycles. For working solutions, prepare them fresh before use and avoid prolonged storage. Also shield antibodies from intense light, as some fluorescent secondary antibodies are light sensitive and will not be active when in contact with light in some experiments.

Spotted background is often caused by particulate impurities in the blocking solution or aggregation of the secondary antibody. To address this, filter both the blocking solution and the secondary antibody to remove any particles. Additionally, ensure that the incubation solutions are well-mixed during the process and avoid using reagents that have precipitated. You can optimize each step, and adjust experimental conditions as per the specific problems, and the success and data quality of Western Blot experiments can greatly improve. If it continues to malfunction, follow the manufacturer’s advice or ask technical support for further information.

If you want to get more antibody specificity in WB, here are a few tips:

• Choose High-Quality Antibodies

Use tested-and-proven antibodies. Choose your antibody depending on the need. Monoclonal and affinity-purified polyclonal antibodies are generally more specific. The recombinant monoclonal antibodies, optimized using genetic engineering, are more specific and reproducible.

• Optimize Experimental Conditions

Improving specificity often involves fine-tuning experimental parameters. Using the proper blocking agent (BSA or nonfat milk) to reduce nonspecific binding and selecting the correct buffer for primary antibody dilution as specified by the manufacturer. Set the primary antibody incubation parameters (temp and time) to minimize nonspecific binding and maximize specific binding.

• Adjust Experimental Parameters

Overloading protein samples can lead to nonspecific bands. Reduce the amount of sample loaded to improve band clarity. Ensure proper transfer conditions—proteins should be fully transferred but not excessively so, to avoid loss of target proteins or excessive background. Additionally, select the appropriate gel concentration based on the size of your target protein to achieve optimal separation.

• Check Storage and Handling Practices

Ensure that antibody levels are properly stored. Conserve antibodies at recommended storage temperatures (-20°C or -80°C) and do not freeze-thaw them in the same batch again, by aliquoting. Prep new working solutions of primary antibodies for use and do not store dilute solutions for long periods of time as this will degrade or cause contamination.

If you take these steps and work hard on optimizing every step of your protocol, then antibodies will be significantly more specific in WB experiments, and the data will be more consistent and precise.

Use Appropriate Controls:

• Positive control: Select a cell line or tissue known to express the target protein to ensure the antibody can detect the expected signal. Successful staining in the positive control confirms the antibody's functionality under the experimental conditions.
• Negative control: Pre-test with a cell line or tissue lacking the target protein to see if the antibody has nonspecific binding.
• Absence of primary antibody control: Stain only background with control secondary antibody.
• Isotype control: Substitute an immunoglobulin with the same isotype but non-target specific to test for nonspecific staining.

Assess Antibody Specificity:

• Gene knockout or knockdown: Use CRISPR/Cas9-mediated knockout or siRNA knockdown of the target protein and observe whether ICC signals are significantly reduced or eliminated. This serves as a robust method for validating specificity.
• Regulation of target expression: Modulate the expression or activity of the target protein and monitor whether ICC signals change accordingly. Signal intensity should correlate with target protein levels.
• Validation with independent antibodies: Use another antibody that recognizes a different epitope of the same target protein and compare staining patterns. Consistent results strengthen confidence in specificity.

Cross-Validation with Other Techniques:

• WB: Assure the target protein shows as a single band of expected molecular weight and therefore specificity.
• IF and IHC: Validate antibody performance with the aid of these inter-modal methods, with staining consistent between techniques.
• IP-MS: Purify the target protein via IP and confirm through MS that the antibody attaches to the target protein.

Optimizing Primary Antibody Incubation Time:

Commonly recommended incubation times include short-term incubation at room temperature (RT) and long-term incubation at low temperatures (4°C). For low-abundance targets, overnight incubation can enhance signal intensity.

The incubation time is influenced by both the antibody concentration and the target protein's abundance. During preliminary experiments, test various incubation durations and evaluate changes in the signal-to-noise ratio. If background staining is high, consider shortening the incubation time or reducing the primary antibody concentration.

Optimizing secondary antibody incubation time:

Secondary antibodies are typically incubated at room temperature for 30 minutes to 1 hour. Some commercial kits may suggest even shorter incubation times.

Be careful not to prolong secondary antibody incubation as it might lead to extra nonspecific binding. Moreover, with fluorescent secondary antibodies, keep incubation in a dark room to avoid photobleaching the fluorescent signal.

Balancing temperature and incubation time:

Short-term incubation at room temperature is suitable for rapid experiments but may result in higher background signals. Low-temperature, long-term incubation (e.g., overnight at 4°C) improves specificity, particularly for high-affinity antibodies or complex samples.

If a shorter experimental timeline is required, increasing the antibody concentration at room temperature can compensate for reduced incubation time. However, this approach should be carefully optimized to avoid excessive nonspecific binding.

Estimate Antibody Binding Efficiency Based on Fluorescent Signal Strength:

• Fluorescence Microscopy: fluorescently marked antibodies to study staining and aliquoting of target protein. Be sure that the signal strength matched the expression profile of the target protein you are testing.
• Quantitative Analysis: Employ image analysis software to measure the fluorescence intensity, allowing for a quantitative assessment of antibody binding efficiency. Compare signal intensities between experimental and control groups to confirm specific binding.

Perform Quantitative Detection with Flow Cytometry:

• Luminescently label cells with antibodies and measure fluorescence. This is single-cell resolution and measures MFI, a measure of antibody binding efficiency.
• Flow cytometry is ultra-sensitive, very fast and high throughput, and is perfect for measuring antibody binding under various experimental conditions.

Set Up Appropriate Controls:

• Positive Control: Use cell lines or samples with known high expression of the target protein to ensure the antibody can detect the expected signal.
• Negative Control: Test for nonspecific staining using cell lines or tissues that do not carry the target protein. Don't add the primary antibody, and only the secondary antibody to look at background staining.
• Blocking Control: Pre-incubate the antibody with its immunogen (e.g., peptide) before staining. A significant reduction or absence of signal confirms specific binding.

• High Background Signal: This may be caused by non-specific binding. Use less antibody, or affinity-purified antibodies are suggested.
• Target Protein Not Detected in Elution Buffer: This could be due to low expression of target protein in sample. You can increase the amount of the lysate but remember, it increases non-specific binding.
• Co-elution of Antibody and Target Protein: To avoid signal overlap, it is advisable to use antibodies from different species for the IP and WB experiments.
• Sample Degradation: Ensure that freshly prepared protease inhibitors are used during the lysis process and maintain operations at low temperatures to prevent protein degradation.
• Non-specific Binding Issues: Non-specific binding can be reduced by pre-purifying the lysate or using an irrelevant antibody of the same subclass as the target antibody for pre-treatment.

Avoid IgG overlap signal problems with WB by using antibodies from different species during IP and WB. Furthermore, using the right secondary antibodies can reduce the noise.

(1) Select Appropriate Antibodies

• Specificity and Affinity: Choose monoclonal antibodies that bind the desired protein and that are highly specific and affinity. You can look in literature or from suppliers to choose antibodies approved for IP.
• Commercially Available Biotinylated Antibodies: There are many antibodies that can be biotinylated so they can be snipped with streptavidin beads and will better adhere.

(2) Optimize Incubation Conditions

• Incubation Time and Temperature: Perform incubations at suitable temperatures (typically 4°C or room temperature) and adjust the incubation duration based on the abundance of the target protein. This can result in better binding if the incubation period is extended (even overnight).
• Gentle Mixing: While incubating mix the lysate gently so the antigen and antibody can interact and create stable immune complexes.

(3) Adjust Washing Conditions

• Washing Buffer: Use an appropriate washing buffer (such as PBS with low concentrations of detergents) to reduce non-specific binding while preserving the antigen-antibody complex. Optimizing washing conditions can involve adjusting salt concentration and pH.
• Increase Washing Steps: Performing multiple washes can effectively remove unbound proteins, reducing background signals and improving the signal-to-noise ratio.

(4) Use Crosslinking Agents

In some cases, antigen-antibody complexes can be stabilized with crosslinking agents. This is particularly effective for proteins with weak interactions.

(5) Pre-purify Samples

Before conducting IP, pre-treating the lysate with similar components can help reduce impurities in the lysate, thereby enhancing both the recovery rate and binding efficiency of the target protein.

• Do Not Use Homologous Antibodies: Make sure the antibodies are not the same species as the samples in question (IgG in serum) to avoid competitive binding.
• Biotinylated Antibodies: Most antibodies are biotinylable and could be captured using streptavidin beads (to minimize competition with other antibodies).
• Pre-clean the Samples: Prior to IP, wash the sample first with an irrelevant antibody from the same species as the target antibody to eliminate things that might block binding such as normal serum.
• Adjust the Order of Addition: First, bind the antibody to a solid support (such as Protein A/G beads), and then add the lysate containing the target protein. This approach can reduce competition between antibodies and other proteins.
• Lower Sample Concentration: In IP experiments, reducing the total protein concentration in the cell lysate can decrease opportunities for non-specific binding and competitive interactions. Ensure that the concentration of the target protein is adequate to facilitate specific binding.

FC works with monoclonal and polyclonal antibodies. mAbs are more specific, but pAbs can be more sensitive because they recognize more than one epitope. One should look for antibodies that are proven to work on FC.

You have to titrate antibodies when they’re new in the experimental setting, when cell types are changed, or when you switch fluorochromes. A titration series will usually have several different antibodies tested at different concentrations, to determine the best dilution and signal-to-noise ratio. This process should be performed on the same cell type intended for staining in the actual experiment.

• Weak or No Signal: This can be caused by low antibody concentration, bad fixation or permeabilization, or low expression of the target protein. It can be solved by upping the amount of antibody or fixing fixation.
• High Background Staining: High background can result from excessive antibody use or non-specific binding. Reducing antibody concentration and ensuring proper blocking steps can minimize background staining.
• Non-specific Binding: This is usually due to autofluorescence or in the wrong antibody choice. When used with negative control, non-specific signals can be picked up.

Choose fluorochromes that are bright, have a spread in spectral distribution and overlap with the other fluorochromes in your panel. Lighter fluorochromes are good for more obscure targets, but these can improve sensitivity.

Also, always include positive and negative controls. Positive controls make sure your staining is going as planned, and negative controls filter out errant signals and unspecific binding.

Be sure to use positive and negative controls in your experiments. Positive controls check if your staining is accurate, and negative controls block unwanted signals and non-specific binding.